ey0016.13-1 | Diabetes | ESPEYB16
PC Rockers
, RO Laing
, PG Ashigbie
, MA Onyango
, CK Mukiira
, VJ Wirtz
Lancet Glob Health 2019;7: e492502. DOI: 10.1016/S2214-109X(18)30563-1• The authors evaluated the effect of a Novartis programme that provides metformin at a wholesale price of US$1 per month in Kenya.• This cluster-randomized controlled trial significantly increased the availability of metformin at health facilities, but not at patient househ...